REDEYE Releases 2cureX Equity Research Report

Mon, Aug 31, 2020 09:36 CET

Redeye initiates coverage of 2cureX, a diagnostics company set to commercialize its Microtumor cancer test IndiTreat® within Colorectalcancer.

2cureX is a Medtech company that has developed the IndiTreat test for Individualizing the treatment of cancer patients. 2cureX strives to establish IndiTreat as a global standard for Functional Precision Medicine.